Influenza Season Winds Down, but Not Done Yet, CDC Says Influenza Season Winds Down, but Not Done Yet, CDC Says
This influenza season is in its final stages but influenza is not completely gone just yet, according to the CDC.Medscape Medical News (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - May 25, 2019 Category: Pathology Tags: Infectious Diseases News Source Type: news

CDC: Flu season wraps up as a few cases linger
The Centers for Disease Control and Prevention released its last weekly influenza report Friday, and flu activity remained similarly low to last week. This caps off the longest flu season in a decade. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 24, 2019 Category: Consumer Health News Source Type: news

Spanish flu may have lingered two years before 1918 outbreak and vaccine could have treated it
(Taylor& Francis Group) The most severe pandemic in recent history, killing some 50 million people worldwide, the Spanish influenza, may have emerged up to two years earlier than previously believed. And, according to a new and influential study, its early manifestation was ignored at the time as a 'minor infection.' (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 23, 2019 Category: Infectious Diseases Source Type: news

Flu outbreak sickens over 30 migrants at border center
More than 30 migrants have tested positive for influenza at a major processing center on the Mexican border that was temporarily closed to stop the outbreak (Source: ABC News: Health)
Source: ABC News: Health - May 23, 2019 Category: Consumer Health News Tags: Health Source Type: news

NIH announces two awards for multi-year studies of influenza immunity in children
Grants may total more than $64 million over seven years. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - May 22, 2019 Category: American Health Source Type: news

IntraHealth ’s Jeanne Tessougué of Mali Honored as Heroine of Health during World Health Assembly
May 22, 2019Women in Global Health honored IntraHealth International ’sJeanne Tessougu é as a Heroine of Health Sunday during the 72nd annual World Health Assembly in Geneva. Tessougu é was one of seven women honored for their leadership in improving health care and advancing gender equality. The annual Heroines of Health awardshighlight women ’s major contributions to the global health care industry. Women currently hold 70% of jobs in the industry and contribute nearly $3 trillion to the health and social sectors,according to Women in Global Health, yet comprise a small percentage of global...
Source: IntraHealth International - May 22, 2019 Category: International Medicine & Public Health Authors: intrahealth Tags: Mali Mali Human Resources for Health Strengthening Activity World Health Assembly Health Workforce & Systems Source Type: news

Canadian researchers on promising path towards developing flu treatment using lipid target
(McGill University Health Centre) A team of scientists of the Research Institute of the McGill University Health Centre (RI-MUHC) in Montreal, Canada   , has tackled this fundamental question and recently identified a target to 'tone down' the hyper-active immunity to influenza infection. These novel findings have promising clinical implications in the near future for the treatment of flu. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 22, 2019 Category: International Medicine & Public Health Source Type: news

NIAID announces two awards for multi-year studies of influenza immunity in children
(NIH/National Institute of Allergy and Infectious Diseases) The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has announced two awards for the study of influenza immunity in children. The awards, which may total more than $64 million over seven years, will support studies led by Cincinnati Children's Hospital Medical Center and St. Jude Children's Research Hospital, examining how young children's immune systems respond over multiple years to their initial influenza infection and their first vaccination. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 22, 2019 Category: Infectious Diseases Source Type: news

St. Jude gets $34M to study flu virus
St. Jude Children ’s Research Hospital was founded to fight cancer but is also among the global leaders in influenza research. A person’s lifelong response to the flu may be determined early in life, and a new effort led St. Jude aims to understand that process. And, that research may eventually help create a u niversal flu vaccine. “There is evidence that the very first flu virus encountered — whether as an infection or vaccination — ‘imprints’ on the developing immune system and… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 20, 2019 Category: American Health Authors: Jason Bolton Source Type: news

New single vaccination approach to killer diseases
(University of Adelaide) Scientists from the University of Adelaide's Research Centre for Infectious Diseases have developed a single vaccination approach to simultaneously combat influenza and pneumococcal infections, the world's most deadly respiratory diseases. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 20, 2019 Category: Infectious Diseases Source Type: news

Virulence factor of the influenza A virus mapped in real-time
(Kanazawa University) In a recent study published in BBA -- General Subjects, Kanazawa university researchers have used high-speed microscopy to investigate native structure and conformational dynamics of hemagglutinin in influenza A. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 20, 2019 Category: Infectious Diseases Source Type: news

Human antibody reveals hidden vulnerability in influenza virus
Discovery by NIAID-funded researchers could aid quest for universal flu vaccine. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - May 16, 2019 Category: American Health Source Type: news

Human antibody reveals hidden vulnerability in influenza virus
(NIH/National Institute of Allergy and Infectious Diseases) The ever-changing 'head' of an influenza virus protein has an unexpected Achilles heel, report NIAID-funded scientists. The team discovered the structure of a naturally occurring human antibody that recognizes and disrupts a portion of the hemagglutinin (HA) protein that the virus uses to enter and infect cells. The investigators determined that the antibody, FluA-20, binds tightly to an area on the head of the HA protein that is only briefly accessible to antibody attack. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 16, 2019 Category: International Medicine & Public Health Source Type: news

How proteins help influenza A bind and slice its way to cells
(eLife) Researchers have provided new insight on how two proteins help influenza A virus particles fight their way to human cells. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 14, 2019 Category: Infectious Diseases Source Type: news

CDC Guidance for Swine Influenza Virus Infection CDC Guidance for Swine Influenza Virus Infection
Human infection with swine flu viruses can occur. Here's how to diagnose and treat swine flu.CDC Expert Commentary (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - May 9, 2019 Category: Infectious Diseases Tags: Infectious Diseases Commentary Source Type: news

Use of antiviral medicines in primary care (England) – prescribers and community pharmacists
Antiviral medicines may no longer be prescribed and dispensed in primary care for the prevention and treatment of influenza at NHS expense. This does not impact on prescribing of antiviral medicines (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 8, 2019 Category: Drugs & Pharmacology Source Type: news

The UK's pandemic influenza research portfolio: a model for future research on emerging infections
In this Personal View, the authors describe the projects that were set up, the challenges of putting these projects into a maintenance-only state, and ongoing activities to maintain readiness for activation, and discuss how to plan research for a range of major incidents. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 7, 2019 Category: Consumer Health News Source Type: news

Germany Might Make Measles Vaccinations Mandatory
Lawmakers in Germany are considering a new law that would fine parents if their children aren’t vaccinated against measles. The Guardian reports that the draft law would make vaccinations mandatory for any child attending nurseries or schools, as well as teachers, educators and medical staff. Failure to comply could result in fines of up to US$2,800. If approved this year, the law would go into effect by March 1, 2022, and would require parents to provide proof of their children’s vaccination by mid-2020. The proposed measure comes amid a global resurgence of the respiratory illness that has been driven in part...
Source: TIME: Health - May 7, 2019 Category: Consumer Health News Tags: Uncategorized Germany onetime overnight Source Type: news

Anti-vaccination: How TECHNOLOGY is key to solving poor vaccination rates
ANTI-VACCINATION is a rising issue around the World and is currently causing cases of influenza and other associated diseases to spread easily around the UK and Europe. New research suggests technology could help prevent disease in elderly populations. (Source: Daily Express - Health)
Source: Daily Express - Health - May 5, 2019 Category: Consumer Health News Source Type: news

Hospital gets $30M to develop universal flu vaccine
Cincinnati Children ’s Hospital has landed a $30 million federal grant – the second-largest the medical center has ever received – to develop a universal influenza vaccine. The grant from the National Institute of Allergy and Infectious Diseases will fund research based at the hospital in Avondale, which will fo cus on how the immune systems of infants and children are affected by first exposures to flu viruses.  More than 2,000 sets of mothers and infants from Greater Cincinnati and Mexico… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 2, 2019 Category: Biotechnology Authors: Barrett J. Brunsman Source Type: news

Cincinnati Children ’s lands second-largest grant ever
Cincinnati Children ’s Hospital has landed a $30 million federal grant – the second-largest the medical center has ever received – to develop a universal influenza vaccine. The grant from the National Institute of Allergy and Infectious Diseases will fund research based at the hospital in Avondale, which will fo cus on how the immune systems of infants and children are affected by first exposures to flu viruses.  More than 2,000 sets of mothers and infants from Greater Cincinnati and Mexico… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 2, 2019 Category: Biotechnology Authors: Barrett J. Brunsman Source Type: news

Major grant fuels hunt for universal flu vaccine
(Cincinnati Children's Hospital Medical Center) 2nd-largest grant Cincinnati Children's has ever received will help accelerate the chase for one of medicine's most elusive goals: a universal influenza vaccine. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 2, 2019 Category: Infectious Diseases Source Type: news

Exploring Lessons Learned from a Century of Outbreaks: Readiness for 2030; Proceedings of a Workshop
Source: National Academies Press (NAP). Published: 5/2019. In November 2018, an ad hoc planning committee at the National Academies of Sciences, Engineering, and Medicine planned two workshops in Washington, DC, to examine the lessons from influenza pandemics and other major outbreaks, understand the extent to which the lessons have been learned, and discuss how they could be applied further to ensure that countries are sufficiently ready for future pandemics. This 210-page publication summarizes the presentations and discussions from both workshops. (Text) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 1, 2019 Category: International Medicine & Public Health Source Type: news

Surveillance Report: Zoonotic Influenza Annual Epidemiological Report for 2018
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 5/2019. This six-page report on cases of zoonotic influenza is based on data for 2018 retrieved on April 3, 2019. No human cases of avian influenza were reported in the European Union/European Economic Area in 2018. Only two human A(H7N9) infections were reported from China, a significant decrease compared with 2017. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 1, 2019 Category: International Medicine & Public Health Source Type: news

510(k) Market Clearance for FluChip-8G Influenza A+B Assay
InDevR receives 510(k) market clearance for the first influenza diagnostic assay capable of distinguishing between seasonal and non-seasonal influenza A subtypes BOULDER, Colo., April 30, 2019 -- (Healthcare Sales & Marketing Network) -- InDevR Inc., a... Diagnostics, FDA InDevR, FluChip, Influenza (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 30, 2019 Category: Pharmaceuticals Source Type: news

510(k) market clearance for FluChip-8G Influenza A+B Assay
(InDevR, Inc.) InDevR Inc., a leader in progressive analytical technologies, announced today that they have received 510(k) market clearance for their FluChip-8G Influenza A+B Assay from the United States Food and Drug Administration (FDA). (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 30, 2019 Category: Infectious Diseases Source Type: news

12 Percent of Caregivers Have Pediatric Flu Vaccine Hesitancy
MONDAY, April 29, 2019 -- Some caregivers of children have influenza vaccine hesitancy and hold inaccurate beliefs about influenza vaccination and disease, according to a study presented at the annual meeting of the Pediatric Academic Societies,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 29, 2019 Category: Pharmaceuticals Source Type: news

H3N2 viruses mutate during vaccine production but new tech could fix it
(University of Wisconsin-Madison) A new technology developed by the University of Wisconsin-Madison's Yoshihiro Kawaoka may make H3N2 vaccine development a bit easier. In Nature Microbiology today [April 29, 2019], Kawaoka and his team describe a new cell line that enables better growth of H3N2 for vaccine use. The virus is also far less likely to mutate during production using this cell line, improving the chances of a match between vaccine and circulating influenza viruses. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 29, 2019 Category: Infectious Diseases Source Type: news

Comment on: New Influenza Drug Brings New Promise
For the treatment of influenza, a full course of therapy ranges in price and is approximately the following, based on recent www.goodrx.com pricing (as of April 5, 2019). When comparing the prices of these agents, note that they will vary depending on dosage form, age, weight, renal function, and other factors for the patient. (Source: Caring for the Ages)
Source: Caring for the Ages - April 27, 2019 Category: Health Management Authors: Karl Steinberg Source Type: news

New Influenza Drug Brings New Promise
Currently the Centers for Disease Control and Prevention (CDC)recommend that everyone 6 months of age and older receive a flu vaccine every season. Because the influenza virus replicates and mutates frequently, the vaccine often does not contain all the strains that people are infected with. (Source: Caring for the Ages)
Source: Caring for the Ages - April 27, 2019 Category: Health Management Authors: Jeanne Manzi Tags: PALTC Pharmacy Source Type: news

El resfriado y la gripe: prevenci ón, síntomas y tratamientos
En gran parte del hemisferio norte, ésta es la temporada perfecta para contraer un resfriado, la influenza (gripe) y otras enfermedades respiratorias. Aunque los virus contagiosos se mantienen activos durante todo el año, la mayoría de las infecciones ocurre en el otoño y el invierno. (Source: FDA Consumer Health Information Updates)
Source: FDA Consumer Health Information Updates - April 27, 2019 Category: Consumer Health News Authors: FDA Source Type: news

New AAP PROS study assesses influenza vaccine hesitancy among caregivers of children
(Pediatric Academic Societies) Even caregivers whose children receive the first dose of influenza vaccine may be vaccine hesitant and have inaccurate beliefs regarding influenza vaccine and disease, according to a new American Academy of Pediatrics Pediatric Research in Office Settings study. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 27, 2019 Category: International Medicine & Public Health Source Type: news

La FDA aprueba nuevo medicamento para tratar la influenza
(Source: Food and Drug Administration)
Source: Food and Drug Administration - April 27, 2019 Category: American Health Authors: FDA Source Type: news

Influenza Season Now Longest in a Decade, CDC
Reports (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 23, 2019 Category: General Medicine Source Type: news

Eating elderberries can help minimize influenza symptoms
(University of Sydney) Conducted by Professor Fariba Deghani, Dr. Golnoosh Torabian and Dr. Peter Valtchev as part of the ARC Training Centre for the Australian Food Processing Industry that was established within the university's Faculty of Engineering and IT, the study showed that compounds from elderberries can directly inhibit the virus's entry and replication in human cells, and can help strengthen a person's immune response to the virus. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 23, 2019 Category: Infectious Diseases Source Type: news

A Vicious, Untreatable Killer Leaves China Guessing
African swine fever, which harms pigs but not humans, has swept across the country, the world ’ s largest pork producer. And the government knows about only some of the cases. (Source: NYT Health)
Source: NYT Health - April 23, 2019 Category: Consumer Health News Authors: RAYMOND ZHONG and AILIN TANG Tags: Pigs Agriculture and Farming China Shandong Province (China) Livestock Diseases Politics and Government Pork Swine Influenza Epidemics Meat Source Type: news

Influenza Season Now Longest in a Decade, CDC Reports Influenza Season Now Longest in a Decade, CDC Reports
Influenza activity is the highest in 10 years, and although activity is subsiding, it is still elevated, possibly because of a second wave of illness with a new predominant virus, according to the CDC.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 23, 2019 Category: Allergy & Immunology Tags: Internal Medicine News Source Type: news

Baloxavir Marboxil: A Flu Antiviral With a Novel Mechanism Baloxavir Marboxil: A Flu Antiviral With a Novel Mechanism
Baloxavir marboxil is a newly approved treatment for influenza. Learn more about the antiviral mechanism of action of this agent.Pediatric Pharmacotherapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 18, 2019 Category: Consumer Health News Tags: Pediatrics Journal Article Source Type: news

Mauritius: Anti-Influenza Vaccination Exercise for Winter 2019 Kicks Off
[Government of Mauritius] The annual anti-influenza vaccination exercise for the winter season 2019 kicked off today at the Bambous Social Welfare Centre in the presence of the Minister of Social Security, National Solidarity, and Environment and Sustainable Development, Mr Etienne Sinatambou. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 17, 2019 Category: African Health Source Type: news

Hospital nursing staff may ‘spread flu before symptoms appear’
A substantial proportion of hospital patients and healthcare workers shed the influenza virus before the appearance of clinical symptoms, according to Swiss researchers who examined flu transmission. (Source: Nursing Times)
Source: Nursing Times - April 16, 2019 Category: Nursing Source Type: news

Mauritius: Mauritius Launched Its Seasonal Influenza Vaccination Programme for 2019
[WHO] The Seasonal Influence Vaccination Programme for 2019 was officially launched on 11 April 2019 by Dr Hon. Anwar Husnoo, Minister of Health and Quality of Life at Dr. Hyderkhan Mediclinic in Plaine-Verte, Mauritius. The event was attended by the general population and other relevant personalities including Dr. Laurent Musango, WHO Representative in Mauritius who sets the example by receiving the first influenza vaccine for this year-round. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 11, 2019 Category: African Health Source Type: news

Medical News Today: What are the side effects of Tamiflu in children?
Tamiflu is a prescription drug that doctors sometimes use to treat the influenza, or flu, virus. In this article, learn about the possible side effects and risks in children. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 8, 2019 Category: Consumer Health News Tags: Pediatrics / Children's Health Source Type: news

Medical News Today: Could this food additive make it harder to fight the flu?
A compound called tert-butylhydroquinone (tBHQ) weakens the body's immune response to influenza infections, new research suggests. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 8, 2019 Category: Consumer Health News Tags: Flu / Cold / SARS Source Type: news

Scientists review influenza vaccine research progress and opportunities
Experts in immunology, virology, epidemiology, and vaccine development detail efforts to improve seasonal influenza vaccines. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - April 8, 2019 Category: American Health Source Type: news

Scientists review influenza vaccine research progress and opportunities
(NIH/National Institute of Allergy and Infectious Diseases) In a new series of articles, experts in immunology, virology, epidemiology, and vaccine development detail efforts to improve seasonal influenza vaccines and ultimately develop a universal influenza vaccine. The 15 articles are part of a supplement in the April 15 issue of the Journal of Infectious Diseases. Researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and scientists supported by NIAID, are among the contributing authors. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 8, 2019 Category: International Medicine & Public Health Source Type: news

Vaccine report calls for innovative transformation strategies to increase influenza immunization rates in underserved communities
(PadillaCRT) Sustainable Healthy Communities announced the publication of a summary report in Vaccine, the leading peer-reviewed journal focused on immunization science, urging health systems, providers and community stakeholders to implement evidence-based strategies to address racial disparities in influenza immunization. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 8, 2019 Category: International Medicine & Public Health Source Type: news

From essential oils to powerful teas, here are natural remedies that effectively fight the flu
(Natural News) No one wants to get sick, even if the disease is “merely” influenza. Fortunately, preppers can access many natural ways to treat flu and alleviate the symptoms of the ailment. Essential oils are a rich source of natural healing properties. Every prepper should stock a standard supply of these oils for treating all kinds of illness. The essential oils can... (Source: NaturalNews.com)
Source: NaturalNews.com - April 8, 2019 Category: Consumer Health News Source Type: news

First Human Trial of Universal Flu Vaccine Underway First Human Trial of Universal Flu Vaccine Underway
The first-in-human trial of a universal influenza vaccine candidate is currently underway at the National Institutes of Health, researchers have announced.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - April 5, 2019 Category: Intensive Care Tags: Infectious Diseases News Source Type: news

National Institutes Of Health Begin Human Trial Of ‘ Universal ’ Flu Vaccine
BOSTON (CBS) – Four children have died from the flu in Massachusetts so far this season, a stark reminder of why it’s so important to get vaccinated every year. Now, the National Institutes of Health has begun the first human trial of a “universal” flu vaccine. This novel flu vaccine was designed to provide long-lasting protection for all age groups against multiple influenza subtypes, including seasonal flu viruses and those that can cause deadly pandemics. This first study is a Phase 1 trial which will look at the vaccine’s safety and side effects, as well as how robustly it stimulates the i...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 4, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Healthwatch Syndicated Local Dr. Mallika Marshall Flu Vaccine Source Type: news

First Human Trial of Universal Flu Vaccine Candidate Underway First Human Trial of Universal Flu Vaccine Candidate Underway
The first-in-human trial of a universal influenza vaccine candidate is currently underway at the National Institutes of Health, researchers have announced.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 4, 2019 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news